In vitro studies of a new semisynthetic penicillin, 6-(d-alpha-sulfoaminophenylacetamido)-penicillanic acid.
The activity of 6-(D-alpha-sulfoaminophenylacetamido)-penicillanic acid was determined against 357 clinical isolates of gram-negative bacilli by use of the tube-dilution technique. The majority of the isolates of Pseudomonas species were inhibited by 200 mug/ml or less of this antibiotic. Most of the isolates of Escherichia coli had a minimal inhibitory concentration of 50 mug/ml or less. Seventy-three per cent of the isolates of P. mirabilis, 40% of the isolates of P. morganii, and 45% of the isolates of Enterobacter species were inhibited by 12.5 mug/ml or less, whereas most of the isolates of Klebsiella species and Serratia species were resistant. The activity of this semisynthetic penicillin was affected by the size of the inoculum. The drug was bactericidal against all isolates of E. coli and Proteus species that were sensitive to it, but it was bactericidal against only 32% of the sensitive isolates of Pseudomonas species.
D001419:Bacteria / Q000187:drug effects*; D001437:Bacteriuria; D001769:Blood / Q000382:microbiology; D004754:Enterobacter / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005243:Feces / Q000382:microbiology; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D010406:Penicillins / Q000138:chemical synthesis / Q000494:pharmacology*; D010614:Pharynx / Q000382:microbiology; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects*; D012705:Serratia / Q000187:drug effects; D013183:Sputum / Q000382:microbiology; D014946:Wound Infection / Q000382:microbiology
D010406:Penicillins